Predictability of cardiotoxicity: Experience of a Belgian cardio-oncology clinic.

[1]  P. Trambaiolo,et al.  ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO) , 2021, European heart journal supplements : journal of the European Society of Cardiology.

[2]  L. Tarantini,et al.  Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey , 2021, Frontiers in Cardiovascular Medicine.

[3]  Kayla L. Stratton,et al.  Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study. , 2020, The Lancet. Oncology.

[4]  S. Dent,et al.  Clinical experience of patients referred to a multidisciplinary cardio-oncology clinic: an observational cohort study. , 2019, Current oncology.

[5]  A. Lyon,et al.  Activity and outcomes of a cardio‐oncology service in the United Kingdom—a five‐year experience , 2018, European journal of heart failure.

[6]  P. Douglas,et al.  Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Guido Strunk,et al.  Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality , 2015, Heart.

[8]  M. Kohli,et al.  Evaluation and management of patients with heart disease and cancer: cardio-oncology. , 2014, Mayo Clinic proceedings.

[9]  R. Hong,et al.  Cardio‐Oncology/Onco‐Cardiology , 2010, Clinical Cardiology.

[10]  D. Mulrooney,et al.  Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort , 2009, BMJ : British Medical Journal.

[11]  C. Schneider,et al.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.

[12]  C. Hudis,et al.  Cardiac dysfunction in the trastuzumab clinical trials experience. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.